[Brachytherapy with palladium-103--a new way to deliver radiation therapy for localized prostatic cancer].
The incidence of prostate cancer is increasing and, due to the use of PSA, more and more patients are diagnosed with localized disease. These patients may be offered treatment with the intent to cure. Traditionally, this has been either by radical prostatectomy or some form of radiation therapy. This article describes the minimally invasive method with permanent seed implantation. The procedure, indications, contraindications, side effects and results from the literature 28 patients have been treated so far with acceptable proximate side effects and reductions in serum-PSA as expected.
Aus
G
G
Dept of Urology, Länssjukhuset Ryhov, Jönköping, Sweden. gunnar.aus@ryhov.ltjkpg.se
Gunnarsson
G
G
Nodbrant
P
P
D001918:Brachytherapy / Q000379:methods*; D006801:Humans; D008297:Male; D008954:Models, Biological; D010165:Palladium / Q000008:administration & dosage*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*; D011868:Radioisotopes / Q000008:administration & dosage*; D019275:Radiopharmaceuticals / Q000008:administration & dosage
D011868:Radioisotopes; D019275:Radiopharmaceuticals; D010165:Palladium